PROPANTHELINE BROMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propantheline Bromide, and what generic alternatives are available?
Propantheline Bromide is a drug marketed by Ascot, Heather, Hikma, Impax Labs, Mylan, Par Pharm, Pvt Form, Sandoz, Tablicaps, and Watson Labs. and is included in eleven NDAs.
The generic ingredient in PROPANTHELINE BROMIDE is propantheline bromide. There are seven drug master file entries for this compound. Additional details are available on the propantheline bromide profile page.
Summary for PROPANTHELINE BROMIDE
US Patents: | 0 |
Applicants: | 10 |
NDAs: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 70 |
Clinical Trials: | 2 |
Patent Applications: | 2,314 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROPANTHELINE BROMIDE at DailyMed |
Recent Clinical Trials for PROPANTHELINE BROMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Hospital Universitário Professor Edgard Santos | Phase 1 |
Chongqing Medical University | Phase 4 |